AAAAAA
Results:
1-17
|
Results: 17
Authors:
Loeffler, DA
Sima, AAF
LeWitt, PA
Citation: Da. Loeffler et al., Ceruloplasmin immunoreactivity in neurodegenerative disorders, FREE RAD RE, 35(2), 2001, pp. 111-118
Authors:
Hutton, JT
Metman, LV
Chase, TN
Juncos, JL
Koller, WC
Pahwa, R
LeWitt, PA
Samii, A
Tsui, JKC
Calne, DB
Waters, CH
Calabrese, VP
Bennett, JP
Barrett, R
Morris, JL
Citation: Jt. Hutton et al., Transdermal dopaminergic D-2 receptor agonist therapy in parkinson's disease with n-0923 TDS: A double-blind, placebo-controlled study, MOVEMENT D, 16(3), 2001, pp. 459-463
Authors:
Heikkinen, H
Nutt, JG
LeWitt, PA
Koller, WC
Gordin, A
Citation: H. Heikkinen et al., The effects of different repeated doses of entacapone on the pharmacokinetics of L-Dopa and on the clinical response to L-Dopa in Parkinson's disease, CLIN NEUROP, 24(3), 2001, pp. 150-157
Authors:
Dewey, RB
Hutton, JT
LeWitt, PA
Factor, SA
Citation: Rb. Dewey et al., A randomized, double-blind, placebo-controlled trial of subcutaneously injected apomorphine for Parkinsonian off-state events, ARCH NEUROL, 58(9), 2001, pp. 1385-1392
Authors:
Damiano, AM
McGrath, MM
Willian, MK
Snyder, CF
LeWitt, PA
Reyes, PF
Richter, RR
Means, ED
Citation: Am. Damiano et al., Evaluation of a measurement strategy for Parkinson's disease: Assessing patient health-related quality of life, QUAL LIFE R, 9(1), 2000, pp. 87-100
Authors:
Hyland, K
Beaman, BL
LeWitt, PA
DeMaggio, AJ
Citation: K. Hyland et al., Monoamine changes in the brain of BALB/c mice following sub-lethal infection with Nocardia asteroides (GUH-2), NEUROCHEM R, 25(4), 2000, pp. 443-448
Authors:
Jorga, KM
Davis, TL
Kurth, MC
Saint-Hilaire, MH
LeWitt, PA
Fotteler, B
Zurcher, G
Rabbia, M
Citation: Km. Jorga et al., Clinical, pharmacokinetic, and pharmacodynamic effects of tolcapone withdrawal in levodopa-treated patients with parkinsonism, CLIN NEUROP, 23(2), 2000, pp. 98-105
Authors:
Loeffler, DA
Camp, DM
Juneau, PL
Harel, E
LeWitt, PA
Citation: Da. Loeffler et al., Purine-induced alterations of dopamine metabolism in rat pheochromocytoma PC12 cells, BRAIN RES B, 52(6), 2000, pp. 553-558
Authors:
LeWitt, PA
Citation: Pa. Lewitt, The challenge of managing mild Parkinson's disease, PHARMACOTHE, 20(1), 2000, pp. 2S-7S
Authors:
LeWitt, PA
Citation: Pa. Lewitt, New drugs for the treatment of Parkinson's disease, PHARMACOTHE, 20(1), 2000, pp. 26S-32S
Authors:
Camp, DM
Loeffler, DA
LeWitt, PA
Citation: Dm. Camp et al., L-DOPA does not enhance hydroxyl radical formation in the nigrostriatal dopamine system of rats with a unilateral 6-hydroxydopamine lesion, J NEUROCHEM, 74(3), 2000, pp. 1229-1240
Authors:
LeWitt, PA
Citation: Pa. Lewitt, Penicillamine as a controversial treatment for Wilson's disease, MOVEMENT D, 14(4), 1999, pp. 555-556
Authors:
Loeffler, DA
Linder, MC
Zamany, M
Harel, E
Paul, MA
Baumann, H
LeWitt, PA
Citation: Da. Loeffler et al., Measurement of acute phase proteins in the rat brain: Contribution of vascular contents, NEUROCHEM R, 24(10), 1999, pp. 1313-1317
Authors:
LeWitt, PA
Citation: Pa. Lewitt, Micrographia after thalamo-mesencephalic infarction, NEUROLOGY, 52(9), 1999, pp. 1921-1921
Authors:
LeWitt, PA
Citation: Pa. Lewitt, Extending the action of levodopa's effects, PARKINSON'S DISEASE: THE TREATMENT OPTIONS, 1999, pp. 141-158
Authors:
LeWitt, PA
Citation: Pa. Lewitt, Pharmacology of dopaminergic agonists for Parkinson's disease, PARKINSON'S DISEASE: THE TREATMENT OPTIONS, 1999, pp. 159-186
Authors:
Loeffler, DA
LeWitt, PA
Juneau, PL
Camp, DM
Arnold, LA
Hyland, K
Citation: Da. Loeffler et al., Time-dependent effects of levodopa on regional brain dopamine metabolism and lipid peroxidation, BRAIN RES B, 47(6), 1998, pp. 663-667
Risultati:
1-17
|